Literature DB >> 30685846

Polysomnographic features of low arousal threshold in overlap syndrome involving obstructive sleep apnea and chronic obstructive pulmonary disease.

Yasuhiro Yamaguchi1, Satomi Shiota2, Yuji Kusunoki3, Hironobu Hamaya4, Masaki Ishii4, Yuzo Kodama2, Masahiro Akishita4, Kozui Kida3, Kazuhisa Takahashi2, Takahide Nagase5, Yoshinosuke Fukuchi2.   

Abstract

PURPOSE: In patients with overlap syndrome (OVS), the pathophysiologies of obstructive sleep apnea (OSA) and chronic obstructive pulmonary disease can interact with one another. Focusing on low arousal threshold, the authors evaluated polysomnographic features of OVS patients.
METHODS: This retrospective, multicenter study was conducted at three hospitals in Japan. Patients aged ≥ 60 years who underwent polysomnography and pulmonary function testing were reviewed. Severity of airflow limitation (AFL) was classified according to the Global Initiative for Chronic Obstructive Lung Disease criteria. Low arousal threshold was predicted based on the following polysomnography features: lower apnea-hypopnea index (AHI); higher nadir oxygen saturation, and larger hypopnea fraction of total respiratory events. These features were compared among patients with only OSA (n = 126), OVS with mild AFL (n = 16), and OVS with moderate/severe AFL (n = 22).
RESULTS: A low arousal threshold was more frequently exhibited by OVS patients with moderate/severe AFL than by those with OSA only (p = 0.016) and OVS with mild AFL (p = 0.026). As forced expiratory volume in 1 s/forced vital capacity (FEV1/FVC) decreased in OVS patients, the mean length of apnea decreased (r = 0.388, p = 0.016), hypopnea fractions increased (r = - 0.337, p = 0.039), and AHI decreased (r = 0.424, p = 0.008). FEV1/FVC contributed to low arousal threshold independent of age, sex, smoking history, hospital, or body mass index in all subjects (OR 0.946 [95% CI 0.909-0.984]) and in OVS patients (OR 0.799 [95% CI 0.679-0.940]).
CONCLUSIONS: This study first described peculiar polysomnographic features in OVS patients with moderate/severe AFL, suggesting a high prevalence of low arousal threshold.

Entities:  

Keywords:  Arousal; Chronic obstructive pulmonary disease; Obstructive sleep apnea; Polysomnography; Spirometry

Year:  2019        PMID: 30685846     DOI: 10.1007/s11325-019-01786-7

Source DB:  PubMed          Journal:  Sleep Breath        ISSN: 1520-9512            Impact factor:   2.816


  21 in total

Review 1.  Phenotyping the pathophysiology of obstructive sleep apnea using polygraphy/polysomnography: a review of the literature.

Authors:  Marcello Bosi; Andrea De Vito; Bhik Kotecha; Luca Viglietta; Alberto Braghiroli; Joerg Steier; Martino Pengo; Giovanni Sorrenti; Riccardo Gobbi; Claudio Vicini; Venerino Poletti
Journal:  Sleep Breath       Date:  2018-01-09       Impact factor: 2.816

Review 2.  Arousal from sleep: implications for obstructive sleep apnea pathogenesis and treatment.

Authors:  Danny J Eckert; Magdy K Younes
Journal:  J Appl Physiol (1985)       Date:  2013-08-29

3.  Obstructive sleep apnea is common in idiopathic pulmonary fibrosis.

Authors:  Lisa H Lancaster; Wendi R Mason; James A Parnell; Todd W Rice; James E Loyd; Aaron P Milstone; Harold R Collard; Beth A Malow
Journal:  Chest       Date:  2009-06-30       Impact factor: 9.410

4.  Outcomes in patients with chronic obstructive pulmonary disease and obstructive sleep apnea: the overlap syndrome.

Authors:  Jose M Marin; Joan B Soriano; Santiago J Carrizo; Ana Boldova; Bartolome R Celli
Journal:  Am J Respir Crit Care Med       Date:  2010-04-08       Impact factor: 21.405

5.  Eszopiclone increases the respiratory arousal threshold and lowers the apnoea/hypopnoea index in obstructive sleep apnoea patients with a low arousal threshold.

Authors:  Danny J Eckert; Robert L Owens; Geoffrey B Kehlmann; Andrew Wellman; Shilpa Rahangdale; Susie Yim-Yeh; David P White; Atul Malhotra
Journal:  Clin Sci (Lond)       Date:  2011-06       Impact factor: 6.124

Review 6.  Sleep disorders in chronic obstructive pulmonary disease: etiology, impact, and management.

Authors:  Rohit Budhiraja; Tauseef A Siddiqi; Stuart F Quan
Journal:  J Clin Sleep Med       Date:  2015-03-15       Impact factor: 4.062

7.  Eszopiclone and Zolpidem Do Not Affect the Prevalence of the Low Arousal Threshold Phenotype.

Authors:  Patrick R Smith; Karen L Sheikh; Camille Costan-Toth; Derek Forsthoefel; Edward Bridges; Teotimo F Andrada; Aaron B Holley
Journal:  J Clin Sleep Med       Date:  2017-01-15       Impact factor: 4.062

8.  Clinical predictors of the respiratory arousal threshold in patients with obstructive sleep apnea.

Authors:  Bradley A Edwards; Danny J Eckert; David G McSharry; Scott A Sands; Amar Desai; Geoffrey Kehlmann; Jessie P Bakker; Pedro R Genta; Robert L Owens; David P White; Andrew Wellman; Atul Malhotra
Journal:  Am J Respir Crit Care Med       Date:  2014-12-01       Impact factor: 21.405

Review 9.  Pathogenesis of obstructive and central sleep apnea.

Authors:  David P White
Journal:  Am J Respir Crit Care Med       Date:  2005-08-11       Impact factor: 21.405

10.  Sleep Apnea and Obstructive Airway Disease in Older Men: Outcomes of Sleep Disorders in Older Men Study.

Authors:  Ying Y Zhao; Terri Blackwell; Kristine E Ensrud; Katie L Stone; Theodore A Omachi; Susan Redline
Journal:  Sleep       Date:  2016-07-01       Impact factor: 5.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.